Accelerating the R&D of next generation antimicrobials

The fight against antimicrobial resistance requires a strong commitment from all stakeholders: academics, biotechnology companies, global industry leaders, healthcare foundations, governments, and public health organizations. DEINOVE actively participates in this dynamic by establishing partnerships at all stages of its R&D process with leaders in basic science clinical research and industry. DEINOVE also contributes to the evolution of the European R&D framework for new antimicrobials with other members of the BEAM alliance (Biopharmaceutical companies from Europe innovating in Anti-Microbial resistance research).